MORRISA GRAY-BROWN: Open Payments
NPI 1609275239 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$616 in 31 payments from 11 companies in 2025. Trend: 2023 $711 · 2024 $696 · 2025 $616
Food & beverage: $616
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $115 |
| Lundbeck LLC | 5 | $104 |
| ABBVIE INC. | 5 | $80 |
| Indivior Inc. | 3 | $76 |
| Alkermes, Inc. | 2 | $55 |
| Otsuka America Pharmaceutical, Inc. | 3 | $50 |
| Janssen Pharmaceuticals, Inc | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: REXULTI, VRAYLAR, SUBLOCADE, AUSTEDO XR, ARISTADA, UZEDY, INVEGA SUSTENNA, ABILIFY ASIMTUFII.
Industry payments across OH — which companies pay providers there.
